Innovation and health package

Download — EESC opinion: Innovation and health package

See EESC opinion in all languages under Related documents at the end of this page.

 

The EESC reflects in the opinion its view on a package of three Commission proposals: COM(2012) 542 final - 2012/0266 (COD), COM(2012) 541 final – 2012/0267 (COD) and COM(2012) 540 final (INT/665 - 666 and 667).

Key points:

  • The EESC welcomes the recast of the current regulatory system by the Commission that goes beyond a mere simplification of the framework and puts in place more effective rules, strengthening the pre‑market approval procedures and in particular the post-market surveillance.
  • The EESC strongly supports the legal form of a "Regulation" instead of a "Directive" so as to reduce the room for diverging interpretation by individual Member States, providing more equality for European patients and a level playing field for suppliers.
  • Beside safety, fast access to the latest medical technologies also represents an important benefit for patients. Considerable delays in accessing the new devices would harm patients by reducing their treatment choices (possibly life-supporting) or at least prevent them from reducing their disabilities and improving their quality of life.
  • The EESC generally supports high standard approval procedures for high-risk MDs and IVDs before entering the market, in which safety and efficacy must be proven by the results of adequate clinical tests and investigations.
  • The EESC welcomes the introduction of a Unique Device Identification (UDI) to be assigned to each device, allowing faster identification and better traceability. The EESC would also welcome a fully workable central registration tool (Eudamed) which would eliminate multiple registrations and considerably decrease the costs for SMEs.

Other relevant EESC opinions on:

For more information please contact the INT Section Secretariat

 

Downloads

  • Presentation by the EC, 26.09.2012

Recommended for you

  • Pharmaceutical package

    Opinion

    Key pointsThe EESC:supports the aim to improve the availability and accessibility of affordable medicines and boost the competitiveness as well as attractiveness of the EU pharmaceutical industry…

  • Patent package

    Opinion

    Key points   The EESC: welcomes the European Commission's plans to take action on supplementary protection certificates (SPCs), and specifically the plan to create a novel centralised SPC…

  • Space package

    Opinion

    Key points The EESC: Is strongly in favour of the promotion of multilateral governance of space traffic within the UN framework, including European actors; Underlines that standards, guidelines…

  • Anti-smuggling package

    Opinion

    The anti-smuggling package, proposed by the European Commission, comprises three elements: a proposed directive on countering migrant smuggling; reinforcing the role of Europol in combatting…

  • Education Package

    Opinion

    Practical informationComposition of the study group & calendarAdministrator in charge:  / Assistant: